OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Ipsen SA/  FR0010259150  /

Cboe Europe CXE
2024-05-29  3:42:25 PM Chg. - Volume Bid9:00:24 AM Ask9:00:24 AM Market Capitalization Dividend Y. P/E Ratio
120.60EUR - 112
Turnover: 13,524.25		 -Bid Size: - -Ask Size: - 10.29 bill.EUR 0.98% 15.76
GlobeNewswire 2:30 PM Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer   
GlobeNewswire 06-05 Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
GlobeNewswire 05-30 NH TherAguix receives FDA Fast Track designation
GlobeNewswire 05-29 GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GlobeNewswire 05-22 GENFIT: May 22, 2024 Combined Shareholders Meeting Results
GlobeNewswire 05-15 Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 05-14 GENFIT Reports First Quarter 2024 Financial Information
GlobeNewswire 05-13 Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticip...
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-02 Ipsen appoints Keira Driansky as EVP, President of North America
GlobeNewswire 04-25 GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
GlobeNewswire 04-24 Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines...
GlobeNewswire 04-22 Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological di...
GlobeNewswire 04-15 GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
GlobeNewswire 04-10 Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
GlobeNewswire 04-05 GENFIT Announces Publication of the 2023 Universal Registration Document and the 2023 Annual Report ...
GlobeNewswire 04-05 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
GlobeNewswire 04-04 GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire 04-02 Ipsen and Sutro Biopharma announce exclusive global licensing agreement for an ADC targeting solid t...
GlobeNewswire 03-21 CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors
GlobeNewswire 03-20 Mountain America Credit Union Partners with Operation Warm to Donate Shoes to Local Children
GlobeNewswire 03-04 Tome Biosciences Forms Science and Technology Advisory Committee
GlobeNewswire 02-29 GENFIT Announces Revenues and Cash Position as of December 31, 2023
GlobeNewswire 02-28 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 02-26 Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as...